Chimeric antigen receptor T cells derived from CD7 nanobody exhibit robust antitumor potential against CD7-positive malignancies.
Year: 2021
Type: article
Abstract: malignancies.
Source: PubMed Central
Authors: Dan Chen, Fengtao You, Shufen Xiang, Yinyan Wang, Yafen Li, Huimin Meng, Gangli An, Tingting Zhang, Zixuan Li, Licui Jiang, Hai Wu, Binjie Sheng, Bozhen Zhang, Lin Yang
Language: English
Topic: CAR-T cell therapy research
Subfield: Oncology
Field: Medicine
Domain: Health Sciences
Open Access status: green
OpenAlex ID: W4206851490
